Biological medicines, including biosimilar medicines are complex and can be difficult for patients and healthcare professionals to understand. As more biosimilar medicines are developed and registered for use in Australia, across a wide range of therapeutic areas, understanding this topic is even more important.
Pharmacists are medicines experts and play a vital role in the management of biological medicines, including biosimilar medicines by demystifying concerns, ensuring their appropriate use and providing patient counselling. With the support of GBMA Education, PSA now offers members in-depth education on biological medicines, including biosimilar medicines and for the first time delivers this education through a mixture of printed and online materials.
Biological medicines, including biosimilar medicines Essential CPE
This Essential CPE will support you to:
- Understand the complex world of biological medicines, including biosimilar medicines.
- Learn everything you need to know about biosimilar medicines, from the manufacturing process through to having a conversation with prescribers and patients about biological medicines, including biosimilar medicines and substitution.
- Ensure your clinical knowledge is up to date with this comprehensive content.
A hard copy will be included for all PSA members with the September 2020 edition of the Australian Pharmacist journal.